Table 2.
Multivariable logistic regression model for TPN.
| OR | 95% CI | P | |
|---|---|---|---|
| 2011 (before legalization) | .038 | ||
| Noncannabis user | Reference | ||
| Cannabis user | 0.12 | (0.02, 0.89) | |
| 2015 (after legalization) | .768 | ||
| Noncannabis user | Reference | ||
| Cannabis user | 0.94 | (0.61, 1.44) | |
| IBD type | .005 | ||
| Crohn’s disease | Reference | ||
| Ulcerative colitis | 0.81 | (0.70, 0.94) | |
| Age (1-year increase) | 0.98 | (0.98, 0.99) | <.001 |
| Male sex | 1.10 | (0.96, 1.27) | .159 |
| Race | .001 | ||
| White | Reference | ||
| Black | 0.88 | (0.61, 1.27) | |
| Hispanic | 0.46 | (0.27, 0.79) | |
| Other | 1.57 | (1.16, 2.14) | |
| Income quartile | .718 | ||
| First | 0.88 | (0.70, 1.10) | |
| Second | 0.96 | (0.79, 1.16) | |
| Third | 0.96 | (0.81, 1.14) | |
| Fourth | Reference | ||
| Type of insurance | .009 | ||
| Private | Reference | ||
| Medicare | 0.85 | (0.71, 1.02) | |
| Medicaid | 1.09 | (0.89, 1.34) | |
| Other | 0.66 | (0.48, 0.90) | |
| AHRQ-Elixhauser Comorbidity ≥3 | 2.83 | (2.43, 3.29) | <.001 |
The interaction between state and time period was significant, P = .049. Abbreviations: CI, confidence interval; IBD, inflammatory bowel disease; OR, odds ratio; TPN, total parenteral nutrition.